- Home
- JILL vs FENC Comparison
JILL vs FENC Comparison
Compare JILL & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- FENC
- Stock Information
- Founded
- JILL 1959
- FENC 1996
- Country
- JILL United States
- FENC United States
- Employees
- JILL N/A
- FENC N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JILL Consumer Discretionary
- FENC Health Care
- Exchange
- JILL Nasdaq
- FENC Nasdaq
- Market Cap
- JILL 233.1M
- FENC 225.4M
- IPO Year
- JILL 2017
- FENC 2001
- Fundamental
- Price
- JILL $18.17
- FENC $9.06
- Analyst Decision
- JILL Buy
- FENC Strong Buy
- Analyst Count
- JILL 3
- FENC 2
- Target Price
- JILL $18.00
- FENC $13.50
- AVG Volume (30 Days)
- JILL 120.3K
- FENC 65.8K
- Earning Date
- JILL 09-03-2025
- FENC 11-06-2025
- Dividend Yield
- JILL 1.78%
- FENC N/A
- EPS Growth
- JILL N/A
- FENC N/A
- EPS
- JILL 2.39
- FENC N/A
- Revenue
- JILL $601,713,000.00
- FENC $33,302,000.00
- Revenue This Year
- JILL $1.16
- FENC $0.96
- Revenue Next Year
- JILL $1.46
- FENC $51.71
- P/E Ratio
- JILL $7.54
- FENC N/A
- Revenue Growth
- JILL N/A
- FENC N/A
- 52 Week Low
- JILL $13.36
- FENC $3.96
- 52 Week High
- JILL $30.40
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- JILL 66.54
- FENC 58.58
- Support Level
- JILL $15.97
- FENC $8.73
- Resistance Level
- JILL $18.38
- FENC $9.29
- Average True Range (ATR)
- JILL 0.82
- FENC 0.32
- MACD
- JILL 0.15
- FENC 0.05
- Stochastic Oscillator
- JILL 92.03
- FENC 87.80
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.